首页> 外文期刊>Kidney International Reports >POINT OF CARE TESTING FOR CAPILLARY CREATININE CONCENTRATION IN PREGNANT WOMEN AT LOW AND HIGH RISK FOR PREGNANCY-RELATED ACUTE KIDNEY INJURY
【24h】

POINT OF CARE TESTING FOR CAPILLARY CREATININE CONCENTRATION IN PREGNANT WOMEN AT LOW AND HIGH RISK FOR PREGNANCY-RELATED ACUTE KIDNEY INJURY

机译:孕妇毛细血管肌酐浓度低,妊娠与妊娠高危急性肾损伤的毛细血管肌酐浓度

获取原文
           

摘要

Introduction: Pregnancy related acute kidney injury (PR-AKI) is associated with increased morbidity and mortality. Diagnosis remains challenging due to gestational physiological adaptations affecting serum creatinine and a lack of definitions validated perinatally. Point of care testing (PoCT) for creatinine has potential to enhance identification and triaging of women at risk of PR-AKI, and may in turn improve prevention, diagnosis and timely treatment. Before implementing creatinine PoCT within maternity care, accuracy must be established in both low-and high-risk pregnant women. This study aimed to i) perform a validation study of PoCT for capillary creatinine using the StatSensor Xpress Creatinine analyser (Nova Biomedical) across all gestations in low-risk women with normal renal function ii) to develop a model to improve PoCT accuracy in low risk women and to test the model in a second cohort of women with PR-AKI risk factors.
机译:简介:妊娠相关急性肾损伤(PR-AKI)与发病率和死亡率增加有关。 由于影响血清肌酐的妊娠生理适应性,诊断仍然挑战,并且缺乏缺乏缺乏定义。 肌酐的护理点测试(POCT)有可能加强患有PR-AKI风险的妇女的鉴定和三环,并且可以改善预防,诊断和及时治疗。 在在孕妇护理中实施肌酐POCT之前,必须在低和高风险的孕妇中建立准确性。 本研究旨在i)使用统计传感器Xpress肌酐分析仪(Nova生物医学)对具有正常肾功能II的低危女性的所有妊娠,对毛细血管肌酐进行POCT用于毛细血管肌酐的验证研究,以开发一种提高低风险的POCT精度的模型 妇女并在具有PR-AKI危险因素的第二次妇女中测试模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号